%0 Journal Article %T Emerging oncogenic fusions other than ALK, ROS1, RET , and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy %A Suda, Kenichi %A Mitsudomi, Tetsuya %J Translational Lung Cancer Research %D 2020 %B 2020 %9 %! Emerging oncogenic fusions other than ALK, ROS1, RET , and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy %K %X %U https://tlcr.amegroups.org/article/view/41144 %V 9 %N 6 %P 2618-2628 %@ 2226-4477